Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01149837 · ClinicalTrials.gov registry record
Evaluation of InnoLIA HTLV I/II Score
A clinical trial of Human T-Lymphotrophic Virus Type I and/or Type II, sponsored by Creative Testing Solutions.
- Completed
- Registry status
- 3,305
- Enrollment target
- 1
- Study location
NCT01149837 is a study of Human T-Lymphotrophic Virus Type I and/or Type II that has completed, run by Creative Testing Solutions. The registered enrollment target is 3,305 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01149837, a study of Human T-Lymphotrophic Virus Type I and/or Type II, has completed, sponsored by Creative Testing Solutions.
- COMPLETED
- Registry status
- 3,305 participants
- Enrollment target
- 1
- Study location
Study Summary
The InnoLIA HTLV I/II Score is an in vitro diagnostic test for confirmation of antibodies to human T-cell lymphotropic virus (HTLV) type I and type II in human blood samples. It is intended as a supplemental test for blood donor samples that are reactive in routine anti-HTLV screening tests. This study will determine if the test is useful for donor counseling purposes.
Conditions Studied
Interventions
- DEVICE InnoLIA HTLV I/II Score line immunoassay
Study Locations (1)
Arizona
- Creative Testing Solutions - Tempe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,305 participants |
| Start Date | 2013-07 |
| Est. Completion | 2019-01-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01149837
The ClinicalTrials.gov registry entry for NCT01149837 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,305 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creative Testing Solutions, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human T-Lymphotrophic Virus Type I and/or Type II appearing as the primary indexed condition, and to 1 intervention - of which InnoLIA HTLV I/II Score line immunoassay is the first listed.
NCT01149837 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT01149837 about?
NCT01149837 is a clinical study titled "Evaluation of InnoLIA HTLV I/II Score". The InnoLIA HTLV I/II Score is an in vitro diagnostic test for confirmation of antibodies to human T-cell lymphotropic virus (HTLV) type I and type II in human blood samples. It is intended as a supplemental test for blood donor samples that are reactive in routine anti-HTLV screening tests. This st...
What is the current status of trial NCT01149837?
This trial is currently completed. The enrollment target is 3,305 participants. The study started on 2013-07. Estimated completion is 2019-01-25.
What conditions does trial NCT01149837 study?
This clinical trial studies the following conditions: Human T-Lymphotrophic Virus Type I and/or Type II.
What interventions are being tested in trial NCT01149837?
The interventions under investigation include: InnoLIA HTLV I/II Score line immunoassay (DEVICE).
Who is sponsoring clinical trial NCT01149837?
This trial is sponsored by Creative Testing Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01149837 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.